Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$881M |
| 2 |
DoorDash
DASH
|
+$403M |
| 3 |
Amgen
AMGN
|
+$403M |
| 4 |
Amazon
AMZN
|
+$282M |
| 5 |
Applied Materials
AMAT
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$592M |
| 2 |
Workday
WDAY
|
+$580M |
| 3 |
United Parcel Service
UPS
|
+$468M |
| 4 |
Apple
AAPL
|
+$438M |
| 5 |
Atlassian
TEAM
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.97% |
| 2 | Healthcare | 19.05% |
| 3 | Consumer Discretionary | 10.13% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Argan
AGX
$8.13B
| $339K | ﹤0.01% |
6,723
| – | – |
|
|
ETWO
2177
DELISTED
E2open Parent Holdings
ETWO
| $339K | ﹤0.01% |
76,473
+18
| +0% | +$73 |
|
2178
IMAX
IMAX
$2.61B
| $339K | ﹤0.01% |
20,968
| – | – |
|
2179
Ethan Allen Interiors
ETD
$583M
| $338K | ﹤0.01% |
9,782
| – | – |
|
2180
Zentalis Pharmaceuticals
ZNTL
$350M
| $338K | ﹤0.01% |
21,457
+2
| +0% | +$28 |
|
|
ARIS
2181
DELISTED
Aris Water Solutions
ARIS
| $338K | ﹤0.01% |
+23,875
| New | +$243K |
|
|
FLNA
2182
Filana Therapeutics
FLNA
$46.4M
| $338K | ﹤0.01% |
16,641
+1
| +0% | +$23 |
|
2183
Pitney Bowes
PBI
$2.46B
| $335K | ﹤0.01% |
77,229
+7
| +0% | +$29 |
|
2184
Cabaletta Bio
CABA
$444M
| $334K | ﹤0.01% |
19,578
+19
| +0.1% | +$408 |
|
2185
Eagle Bancorp
EGBN
$838M
| $332K | ﹤0.01% |
14,136
| – | – |
|
2186
IDT Corp
IDT
$1.64B
| $331K | ﹤0.01% |
8,764
+3
| +0% | +$107 |
|
2187
AvePoint
AVPT
$2.72B
| $330K | ﹤0.01% |
41,767
-3
| -0% | -$24 |
|
2188
Sabre
SABR
$739M
| $329K | ﹤0.01% |
136,316
+108
| +0.1% | +$362 |
|
2189
Weave Communications
WEAV
$522M
| $328K | ﹤0.01% |
+28,613
| New | +$344K |
|
2190
United Natural Foods
UNFI
$3.01B
| $328K | ﹤0.01% |
28,615
+6
| +0% | +$87 |
|
|
AMPS
2191
DELISTED
Altus Power
AMPS
| $326K | ﹤0.01% |
68,309
+45,276
| +197% | +$269K |
|
|
PFC
2192
DELISTED
Premier Financial Corp. Common Stock
PFC
| $326K | ﹤0.01% |
16,069
+2
| +0% | +$42 |
|
2193
Insteel Industries
IIIN
$593M
| $326K | ﹤0.01% |
8,527
-1
| -0% | -$36 |
|
2194
Heartland Express
HTLD
$986M
| $325K | ﹤0.01% |
27,274
+1
| +0% | +$13 |
|
2195
ImmunityBio
IBRX
$7.8B
| $324K | ﹤0.01% |
60,526
+11
| +0% | +$50 |
|
2196
Aecom
ACM
$9.22B
| $324K | ﹤0.01% |
3,302
-13
| -0.4% | -$1.18K |
|
2197
Dine Brands
DIN
$457M
| $323K | ﹤0.01% |
6,946
+1
| +0% | +$46 |
|
2198
Tompkins Financial
TMP
$1.42B
| $321K | ﹤0.01% |
6,376
+1
| +0% | +$51 |
|
|
SPTN
2199
DELISTED
SpartanNash
SPTN
| $320K | ﹤0.01% |
15,857
+2
| +0% | +$43 |
|
|
RWT
2200
Redwood Trust
RWT
$585M
| $320K | ﹤0.01% |
50,246
+68
| +0.1% | +$444 |
|
Similar funds
Janus Henderson Group's Q1 2024 Portfolio in Review
As of Q1 2024, Janus Henderson Group held 2,613 positions worth $183B, up 9.3% from $168B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Janus Henderson Group's Q1 2024 filing shows 67 new, 1,353 increased, 903 reduced and 85 closed positions. Its largest new stake was CG Oncology: 1,521,432 shares worth $66.8M. The largest sale was Abbott, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q1 2024 buy was CG Oncology: 1,521,432 shares worth $66.8M.
- Janus Henderson Group added most to Oracle in Q1 2024, an estimated $881M increase.
- Janus Henderson Group's biggest Q1 2024 reduction was Abbott, cutting an estimated $592M.
- Janus Henderson Group fully exited Immunogen Inc in Q1 2024, selling an estimated $327M.
- Janus Henderson Group's ten largest holdings make up 28% of its $183B portfolio in Q1 2024.
- Janus Henderson Group opened 67 new positions and closed 85 in Q1 2024.
- Janus Henderson Group's portfolio value rose 9.3% quarter-over-quarter to $183B.
Based on Janus Henderson Group's 13F filing for Q1 2024, filed 15 May 2024.